Author： Takalo Mari
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.7, 2013-10, pp. : 795-810
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Targeting Tau Protein in Alzheimer's Disease
By Gong Cheng-Xin Grundke-Iqbal Inge Iqbal Khalid
Drugs & Aging, Vol. 27, Iss. 5, 2010-05 ,pp. :
Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. :
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
By Bak Ann Mosegaard Egefjord Lærke Gejl Michael Steffensen Charlotte Stecher Chalotte Willemann Smidt Kamille Brock Birgitte Rungby Jørgen
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. :
Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. :